Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH1 | P35367 | 1/20 | 0.67 |
| ▸ | SLC6A4 | P31645 | 8/20 | 0.55 |
| ▸ | SLC6A2 | P23975 | 5/20 | 0.55 |
| ▸ | RIPK1 | Q13546 | 1/20 | 0.55 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.45 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.44 |
| ▸ | HTR2A | P28223 | 4/20 | 0.42 |
| ▸ | LTA4H | P09960 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7646958 | 0.89 | HRH1 (0.62) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL5535030 | 0.87 | HRH1 (0.61) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL7653319 | 0.85 | HRH1 (0.59) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL6623226 | 0.85 | HRH1 (0.50) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL1202137 | 0.83 | HRH1 (0.60) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL5542724 | 0.81 | SLC6A4 (0.62) | HRH1SLC6A4SLC6A2RIPK1HTR2A | |
| SCHEMBL1696335 | 0.80 | HRH1 (0.67) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL29815703 | 0.80 | HRH1 (0.67) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL16111413 | 0.80 | HRH1 (0.67) | HRH1SLC6A4SLC6A2RIPK1CYP19A1 | |
| SCHEMBL1569927 | 0.80 | HRH1 (1.00) | HRH1SLC6A4SLC6A2RIPK1HTR2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-1106003-A | Inhibitors of microsomal triglyceride transfer protein and method | BRISTOL MYERS SQIUBB COMPANY (US) | 1995-08-02 | — | — | CN | claimed |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | KURARAY CO., LTD. (JP) | 2024-07-09 | — | — | US | disclosed |
| US-11981763-B2 | Resin composition for stereolithographic modeling | KURARAY NORITAKE DENTAL INC. (JP) | 2024-05-14 | — | — | US | disclosed |
| EP-3900693-B1 | USE OF A RESIN COMPOSITION | KURARAY NORITAKE DENTAL INC (JP) | 2024-03-20 | — | — | EP | disclosed |
| CN-112752776-B | Resin composition for photofabrication | 可乐丽则武齿科株式会社 | 2024-02-09 | — | — | CN | disclosed |
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | KURARAY CO., LTD. (JP) | 2023-11-14 | — | — | US | disclosed |
| EP-4268792-A1 | ADHESIVE COMPOSITION FOR PHOTOFABRICATION ARTICLES | Kuraray Noritake Dental Inc. (JP) | 2023-11-01 | — | — | EP | disclosed |
| WO-2023190931-A1 | RESIN COMPOSITION FOR STEREOLITHOGRAPHY | クラレノリタケデンタル株式会社 | 2023-10-05 | — | — | WO | disclosed |
| WO-2023182514-A1 | ADHESIVE COMPOSITION FOR STEREOLITHOGRAPHIC ARTICLE AND NON-STEREOLITHOGRAPHIC ARTICLE | クラレノリタケデンタル株式会社 | 2023-09-28 | — | — | WO | disclosed |
| US-20230210728-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF | KURARAY NORITAKE DENTAL INC. (JP) | 2023-07-06 | — | — | US | disclosed |
| US-7262212-B2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2007-08-28 | — | — | US | disclosed |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2006-05-04 | — | — | US | disclosed |
| CN-1705670-A | 2, 3-dihydro-6-nitroimidazo [2, 1-b ] oxazole compounds | OTSUKA PHARMA CO LTD (JP) | 2005-12-07 | — | — | CN | disclosed |
| EP-1555267-A1 | 2,3-DIHYDRO-6-NITROIMIDAZO 2,1-b OXAZOLES | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2005-07-20 | — | — | EP | disclosed |
| CN-1149214-C | Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient | ������������ʽ���� | 2004-05-12 | — | — | CN | disclosed |
| US-6492364-B1 | Triazolo and derivatives as chemokine inhibitors | TORAY INDUSTRIES, INC. (JP) | 2002-12-10 | — | — | US | disclosed |
| EP-1067130-A1 | TRIAZOLO DERIVATIVES AND CHEMOKINE INHIBITORS CONTAINING THE SAME AS THE ACTIVE INGREDIENT | TORAY INDUSTRIES, INC. (JP) | 2001-01-10 | — | — | EP | disclosed |
| US-5670526-A | ANTIINFLAMMATORY AGENT, IMMUNOSUPPRESSANT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1997-09-23 | — | — | US | disclosed |
| CN-1106003-A | Inhibitors of microsomal triglyceride transfer protein and method | BRISTOL MYERS SQIUBB COMPANY (US) | 1995-08-02 | — | — | CN | disclosed |
| EP-0485026-A2 | Antimanic phenoxymethylene bisphosphonate derivatives | MERCK SHARP & DOHME LTD. (GB) | 1992-05-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11814454-B2 | Curable composition, and resin composition for stereolithography prepared therefrom | WASF2, COPE, ARCN1 | HRH1 3453/4885SLC6A4 4523/4885SLC6A2 4778/4885 |
| US-20060094767-A1 | 2,3-Dihydro-6-nitroimidazo[2,1-b]oxazoles | NR2C2, NR4A3, NR4A2 | HRH1 668/4885SLC6A4 4191/4885SLC6A2 3396/4885 |
| US-12030970-B2 | Curable composition and stereolithographic resin composition comprising same | ARL1, ASH2L, VCL | HRH1 2443/4885SLC6A4 4503/4885SLC6A2 4818/4885 |
| US-20230210728-A1 | ENERGY RAY-CURABLE COATING MATERIAL FOR THREE-DIMENSIONAL SHAPED ARTICLES, ENERGY RAY-CURABLE MATERIAL KIT FOR THREE-DIMENSIONAL SHAPING INCLUDING SAME, THREE-DIMENSIONAL SHAPED ARTICLE USING SAME, AND METHOD OF PRODUCTION THEREOF | KIT, SETD7, SETDB1 | HRH1 3785/4885SLC6A4 4567/4885SLC6A2 4776/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.